
    
      This is a prospective cohort design. This study will enroll 388 subjects: 81 patients without
      HTN as a reference group, 81 patients with controlled HTN, 55 patients with uncontrolled HTN,
      55 with remodeled RH, and 81 patients with RH to characterize gut microbiota composition.
      Subjects will provide stool samples for analysis. Subjects will also provide a blood sample
      for inflammatory marker and stem cell analysis.
    
  